Hikma Pharmaceuticals plc
(OTC: HKMPY)
|
7:43 PM UTC, 07/02/24 | |||
---|---|---|---|---|
Last: $48.05 | Change: +0.48 | %Change: +1.00% | Volume: 827 |
Open: | $ 47.59 | Volume: | 827 | |
---|---|---|---|---|
High: | $ 48.05 | Yield(%) | 2.99 | |
Low: | $ 47.59 | P/E Ratio (ttm): | 27.19 | |
Dividend ($): | 0.92 | Market Cap ($): | 5.19B | |
EPS ($) | n/a | Shares Out: | 110.94M |
% Price Change (last 4 weeks): | -7.76 |
---|---|
% Price Change (last 13 weeks): | -1.01 |
% Price Change (last 26 weeks): | 3.70 |
% Price Change (last 52 weeks): | -2.69 |
% Price Change (year to date): | 2.56 |
Return on Equity (%): | 8.77 |
---|---|
Return on Assets (%): | 4.15 |
Return on Invested Capital (%): | 12.82 |
Gross Profit Margin (%): | 46.47 |
---|---|
Net Profit Margin (%): | 6.61 |
Operating Profit Margin (%): | 17.08 |
|
|
50-day Moving Average: | $15.92 |
---|---|
200-day Moving Average: | $17.22 |
Avg. Daily Vol. (last 50 days): | 711 |
Avg. Daily Vol. (last 200 days): | 416 |
52-wk high: | $56.63 |
52-wk low: | $42.23 |
Bid: | $n/a |
Ask: | $n/a |
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
|
Hikma Pharmaceuticals plc
1 New Burlington Place London GL W1S 2HR Phone: 44.20.7399.2760 Fax: 44.20.7399.2761 http://www.hikma.com |
Earnings (1year) ($): | 1.72 |
---|---|
Annual Dividend ($): | 1.40 |
Current P/E Ratio (ttm): | 27.19 |
Book Value ($): | 19.88 |
Cash Flow ($): | 3.45 |
Price/Earnings (x): | 27.19 |
---|---|
Price/Sales (x): | 1.76 |
Price/Book (x): | 2.29 |
Price/Cash Flow (x): | 9.51 |
Quick Ratio (x): | 0.90 |
---|---|
Current Ratio (x): | 1.57 |
LT Debt/Equity (x): | 46.86 |
Total Debt/Equity (x): | 54.19 |